期刊文献+

减量促性腺激素释放激素激动剂在促超排卵中的应用 被引量:10

Application of reduced gonadotropin releasing hormone agonist in controlled ovarian hyperstimulation
暂未订购
导出
摘要 目的 比较控制性促超排卵中减量与常规剂量促性腺激素释放激素激动剂( Gn RHa)对于垂体降调节作用的效果。 方法 进行体外受精 -胚胎移植 ( IVF-ET)的患者随机分成两组 ,对照组 98例应用常规剂量 Gn RHa 3 .75mg,减量组 93例应用 Gn RHa1 .2 5mg。两组患者在月经周期第 1 9~ 2 1天肌注不同剂量的 Gn RHa垂体降调节 ,下次月经周期的第 2日测血雌二醇 ( E2 )、卵泡刺激素 ( FSH)及黄体生成素 ( L H)水平 ,并进入促超排卵和体外受精程序 ,比较两组的人绝经期促性腺激素 ( HMG)支数、取卵数、受精胚胎数、移植和冷冻胚胎数、生化妊娠率及药物费用。 结果 两组患者的取卵数、受精胚胎数、移植和冷冻胚胎数、妊娠率、血 E2 、FSH、L H水平无显著差异 ,HMG支数和药物费用有显著差异 ( P<0 .0 1 )。 结论 减量 Gn Objective: To evaluate the effect of a single reduced gonadotropin releasing hormone agonist (GnRHa) 1.25 mg dose and the regular GnRHa 3.75 mg dose on pituitary down-regulation in women undergoing controlled ovarian hyperstimulation (COH). Methods: Patients underwent IVF-ET or ICSI were divided into two groups randomly: the control group with 98 cases received regular GnRHa 3.75 mg and the study group with 93 cases received GnRHa reduced dose 1.25 mg. They started treatment on menstrual cycle day 19~21. The blood levels of E 2, LH and FSH were checked at the next menstrual cycle day 2, and HMG and IVF-ET were administrated. The number of oocytes retrieved, oocytes fertilized, embryos transferred, embryos frozen, pregnancy rates, ampules of HMG and cost of the drugs were recorded. The comparison of means was performed using a two-sample unpaired t-test. Results: There were no statistically significant differences between the two groups in number of oocytes retrieved, oocytes fertilized, embryos transferred, embryos frozen, pregnancy rates and concentrations of E 2, LH and FSH. However, the cost of the drugs and ampules of HMG reduced significantly when compared with the regular dosage group. Conclusion: The reduced dose of GnRHa is still an effective and safe way in COH.
出处 《生殖医学杂志》 CAS 2003年第3期146-149,共4页 Journal of Reproductive Medicine
基金 国家自然科学基金资助课题 ( 3 0 0 0 0 875 ) 北京大学"985"计划资助
关键词 促性腺激素释放激素激动剂 控制性促超排卵 体外受精 曲普瑞林 Gonadotropin releasing hormone agonist Controlled ovarian hyperstimulation In vitro fertilization Triptorelin
  • 相关文献

参考文献8

  • 1Pepperell RJ. Folliculogenesis: the stimulated way[J].Aust N Z J Obstet Gynaecol, 1994,34(3) :272-276.
  • 2Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques[J]. Fertil Steril,2000,73 (4) : 667-676.
  • 3Liu HC, Lai YM, Davis O, et al. Improved pregnancy outcome with gonadotropin releasing hormone agonist(GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality[J]. J Assist Reprod Genet, 1992,9(4) : 338-344.
  • 4Prato BD, Borini A, Trevisi MR. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study [J]. Hum Reprod, 2001,16(7):1409-1414.
  • 5Hsieh Y, Tsai H, Chang C, et al. Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analogue (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program [J ]. Fertil Steril,2000.73(4):817-820.
  • 6Dirnfeld M, Fruchter O, Yshai D. Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation'versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization[J]. Fertil Steril, 1999,72(3):406-411.
  • 7Kavic S, Sauer MV, Lindheim SR. Menses predict successful ovarian down-regulation using GnRH-a prior to IVF-ET[J]. J Assist Reprod Genet, 2000,17 (5) : 296-298.
  • 8Barash A, Weissman A, Manor M. Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program[J]. Fertil Steril,1998,69(3):496-499.

同被引文献74

引证文献10

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部